Introduction
The current use of ECLS extends beyond its most familiar role of providing support for patients with severe respiratory failure to the treatment of patients with various forms of severe hypoxemic or hypercapnic respiratory failure in contexts ranging from bridging patients to lung transplantation to managing pulmonary hypertensive crises.
1 Patients receiving ECLS are mostly mechanically ventilated and sedated; however, these procedures increase the risk of complications related to immobility and mechanical ventilation. 2 ECLS is increasingly being administered to patients with end-stage lung or heart disease as a bridge to transplantation. 3,5 -7 This concept is implemented using a dual lumen cannula 8, 9 and relatively noninvasive TEE guidance 4, 10 and allows sedation free ECLS use in awake patient. A deeper understanding of the pathophysiology of spontaneous breathing during severe lung failure is necessary to enable suggesting ECLS as a safe and valuable alternative to mechanical ventilation for the treatment of patients with respiratory failure. 35 The tracheostomy is a frequently used procedure for the respiratory weaning of ventilated patients. Tracheostomy versus tracheal intubation resulted in better respiratory protection, reduced airway resistance, more effective bronchopulmonary lavage, reduced pulmonary infections, improved patient comfort, and a shorter duration of required sedation. The aim of this study is to assess the possibility and highlight the benefits of lowering the impact of sedation in surgical non-transplant patients on ECLS. The specific objective was to investigate the use of tracheostomy as a bridge to spontaneous breathing on ECLS.
Methods
A total of 95 patients were examined who were treated with ECLS in the intensive care unit during the period from 1.1.2008 to 31.12.2014 in the 10 bed surgical ICU of a university hospital. The inclusion criterion was that ECMO was conducted for at least 24 hours.
Data were collected retrospectively using the perfusionists' ECMO protocols and via a review of patient records. IBM SPSS Statistics, version 23 (International Business Machines Corporation, Armonk, NY) was used to analyze the descriptive data.
Patients were divided into a group with and without tracheostoma and in a survival group and a non-survival group. In addition to general data (age, gender, BMI) for both groups, the duration of time that the ECMO system and tracheotomy were used, the time from tracheotomy to the end of sedation, and the time of tracheotomy to the onset of independent CPAP breathing were analyzed. In addition, comparisons were made regarding the severity of the basic diseases as measured by current standards such as SOFA, SAPS 3, SAPS 2 and the Murray score. The chi-squared test and binary logistic regression were used.
Results
A total of 95 patients (79 males and 16 females) with an average age of 52 years (16-86 years) and an average BMI of 32 kg/m 2 (2.20-88.5 kg/m 2 ) were included in this study. A total of 80 patients were treated with ECLS, 15 patients were treated with iLA (interventional lung assist). The main diagnoses were trauma in 46 patients (48.4%), extrapulmonary sepsis 27 (28.4%), respiratory failure 17 (17.9%) and ECPR 10 (10.5%). A total of 54 patients (56.8%) were weaned from ECLS, 44 (46.3%) patients were discharged from the intensive care unit, and 42 (44.2%) patients were discharged from the hospital [ Table 1 ].
The average duration of ECLS was 235.2 hours (0 h -890.4 h), and the average duration of the iLA was 184.8 hours (2.4 h -382.1 h). The average duration of the hospital stay before ECLS was 187.2 hours,; after ECLS, the average duration distance was 571.2 h (0 h -26661.6 h); and the overall where the average duration of stay was 981.6 h. Of the 95 patients, 65 patients received a tracheostomy, and 5 patients were admitted with a tracheostoma. One patient was cannulated without intubation, one is extubated during ECLS course after 48 hours. 4 patients were extubated after weaning and the removal of ECLS. 19 patients died before the indication to tracheostomy was given. As a primary endpoint, hospitalization was defined in both subgroups, and the secondary endpoints were the successful weaning from ECLS and the transfer from the ICU to the peripheral station. Overall, a significant difference (p <0.05) was found in both primary and secondary endpoints [ Table 2 ].
Discussion
Studies about tracheostomy procedure in patients treated with an extracorporeal procedure were not available at this time. The indication to extubation during ECLS course can always be concerned. In the current cohort, we followed the principle of adequate analgesia (sufentanil), anxiolysis, and delirium prophylaxis (low dose of haloperidol, clonidine, or lorazepam), with the lowest required level of sedation. This drug selection did not suppress spontaneous breathing activity and enabled early and continuous spontaneous breathing, which is a physiologic behavior. 14 However, cisatracurium treatment is associated with decreased mortality among severe hypoxia patients, 15 Sheakar postulated the opposite of "less sedation is more" in this context. 16, 17 In patients with severe lung failure, the ventilator strategy should represent a balance between muscle paralysis in the most hypoxemic patients and the preservation of spontaneous breathing either after improvement in these patients' conditions or during the acute phase for patients with milder forms of respiratory failure. However, the monitoring of plateau pressure, tidal volume, and transpulmonary pressure appears to be crucial to limiting the occurrence of ventilator-induced lung injury. Yoshida raised the questions of when to promote spontaneous respiratory activity in severy lung failure, when to administer a paralytic and how to prevent lung J Swol et al.
deterioration.
18 Cereda discussed the role of alveolar recruitment in this condition. 19 In this context, a high PEEP may improve outcomes and produce small but significant mortality benefits. 20 Nevertheless, to improve the outcomes of patients receiving ECLS, new sedation methods should be developed when sedation is needed. The possibility exists that patients receiving ECLS might not require sedation because previous studies have demonstrated that "awake ECMO" can be used as a bridge to lung transplantation, thereby enabling both clinicians and patients to avoid the complications of sedation and MV. Future studies involving the use of "awake ECMO" are needed to demonstrate its effectiveness.
Complications of sedation and mechanical ventilation
Nosocomial infections, including ventilator-associated pneumonia, are the leading causes of ventilator-associated complications. 21 In total, 77% of patients who receive mechanical ventilation for more than 5 days experience at least one ventilator-associated condition, and 29% of these patients experience an episode of an infection-related ventilation-associated complication. Respiratory and hemodynamic changes that accompany general anesthesia lead to a significant risk of cardiovascular collapse. 22 Research has indicated that the interruption of sedation and analgesia in neonates receiving ECMO is safe and feasible. 23 Authors who have examined animal models have concluded that mechanical ventilation is injurious to the lungs. 4, 24 Venovenous CO 2 removal allows normocarbia to be maintained with a 50% reduction in minute ventilation and may therefore provide effective lung protection as an adjunct to mechanical ventilation. 24 Among patients without ARDS, protective ventilation with lower tidal volumes is associated with better clinical outcomes. 25 The prognosis and outcome of further treatment largely depend on a patient's preprocedural status. Biscotti postulated, it may be safest to perform ECLS cannulation without intubation or general anesthesia in high-risk patients (patients with pulmonary hypertension) due to the severity of these patients' underlying disease processes.
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Examples of the benefits of awake ECMO
ECLS is increasingly being administered to awake patients with end-stage lung or heart disease as a bridge to transplantation. This approach may liberate selected patients from invasive mechanical ventilation and may allow certain patients to undergo extensive physical therapy while receiving extracorporeal support.
1 Critical illness is a well-recognized cause of neuromuscular weakness and impaired physical function. Physical therapy has been demonstrated to be safe and effective for critically ill patients. 26 Ambulatory ECMO is an approach that involves physical rehabilitation and ambulation for patients supported with ECLS. 3 Physiotherapy, including ambulation, can be achieved safely during ECMO if an experienced, multidisciplinary team is administering treatment. 26, 27 These initial cases provide encouraging results with respect to the development of feasible rehabilitation techniques. 28 There are findings demonstrating the feasibility of using ECMO in non-intubated patients. 29 In one study, 3 awake patients received . ECMO support starting 18-35 days prior to transplantation and continuing until the transplantation was performed. All 3 patients fully recovered after transplantation. In particular, they were able to breathe spontaneously, eat and drink; following transplantation, the patients received passive and active physiotherapy. 29 Keller described the transport of a patient receiving awake VA ECMO. 30 Awake ECMO during the bronchoscopic treatment of an airway stenosis using laser resection was also examined. 31 An ambulatory percutaneous artificial lung (PAL) was described by Zhou. However, critical bleeding, thrombosis formation and gas exchanger durability remain major challenges with respect to the long-term use of the ambulatory PAL. 32 
Potential benefits of integrating spontaneous breathing and the awake ECMO concept
The strategy of initiating ECMO in awake and spontaneously breathing patients with heart failure can achieve early multi-organ recovery and provide sufficient time to plan further treatment. Light sedation and spontaneous breathing during VA ECMO can be well tolerated. 33 A patient with severe cardiac failure refractory to conventional medical management underwent ECMO after the first clinical signs of cardiac failure appeared to avoid mechanical ventilation. Hemodynamic stabilization was immediately achieved, vasopressors were subsequently reduced, and the patient's cardiac situation improved, as indicated by an increase in central venous saturation. This strategy avoids complications associated with sedation and mechanical ventilation and leads to the recovery of secondary organ function, allowing for the administration of additional therapy.
Future perspectives
A true artificial lung has the potential to change the treatment paradigm for adults with chronic respiratory failure. 1 The use of minimal long-term ventilatory support in ARDS could also be a new treatment paradigm. 34 In the future, the use of sedatives may need to be significantly altered, and ECMO may become the first-line treatment for acute respiratory distress. 36 The ability to position a dual lumen cannula without TEE or fluoroscopy would provide new, less invasive options for ECMO. 
Conclusions
Tracheostomy can bridge to spontaneous breathing and awake-ECMO in non-transplant surgical patients. The "awake ECMO" strategy may avoid complications related to mechanical ventilation, sedation, and immobilization and provide comparable outcomes to other approaches for providing respiratory support. However, complications associated with patient noncompliance should not be neglected. Contemporary ECMO is safer, less expensive and simpler than ECMO was during prior eras. ECMO is currently ready for widespread evaluation. 37 
